October 2010
Heart;Oct2010 Supplement, pA158
Academic Journal
An abstract of the article "Effency of Triptolide-Coated Stent on Prevent Restenosis" by Ge Hailong, and colleagues is presented.


Related Articles

  • ENDOTHELIAL DYSFUNCTION AND INFLAMMATION. Slevin, M.; McDowell, G. // Medicina Moderna;2014, Vol. 21 Issue 3, p212 

    The article discusses how coating of stents with anti-inflammatory and anti-proliferative drugs such as sirolimus and paclitaxel can help lowering rates of restenosis and prohibiting endothelial dysfunction. Topics discussed include vascular remodeling and inflammatory response during...

  • CLINICAL HIGHLIGHTS.  // RN;Jul2002, Vol. 65 Issue 7, p21 

    Reports developments related to medical care and nursing in the U.S. as of July 2002. Effectiveness of manual therapy for treatment of neck pain; Ability of dairy-rich diet to combat insulin resistance syndrome; Use of radiation to reduce the rate of restenosis in graft and a possible second...

  • EPA in the Prevention of Restenosis Post PTCA. Bowles, Mark Howard; Klonis, Demo; Plavac, Thomas G.; Gonzales, Brenda; Francisco, Dan A.; Roberts, Roger W.; Boxberger, Gregory R.; Poliner, Larry R.; Galichia, Joseph P. // Angiology;Mar1991, Vol. 42 Issue 3, p187 

    The effect of fish oil on restenosis was evaluated in patients undergoing coronary balloon angioplasty. In addition to routine pharmacotherapy, subjects were given 2.8 g of eicosapentanoic acid (EPA) daily. Treatment was started within twenty-four hours after successful percutaneous transluminal...

  • Accelerated endothelialization with a polymer-free sirolimus-eluting antibody-coated stent. Yu, Zhanjiang; Zhu, Huagang; Lü, Shuzheng; Yang, Xiaoda // Journal of Materials Science: Materials in Medicine;Nov2013, Vol. 24 Issue 11, p2601 

    Drug-eluting stents have shown an impressive reduction of in-stent restenosis for many years. However, stent thrombosis due to incomplete/late endothelialization has raised major safety concerns. To overcome these problems, we developed for the first time a polymer-free sirolimus-eluting...

  • MAGNETICALLY TARGETED DELIVERY OF THERAPEUTIC AGENTS TO INJURED BLOOD VESSELS FOR PREVENTION OF IN-STENT RESTENOSIS. Chorny, Michael; Fishbein, Ilia; Adamo, Richard F.; Forbes, Scott P.; Folchman-Wagner, Zoë; Alferiev, Ivan S. // Methodist DeBakey Cardiovascular Journal;Jan2012, Vol. 8 Issue 1, p23 

    Magnetic guidance is a physical targeting strategy with the potential to improve the safety and efficacy of a variety of therapeutic agents - including small-molecule pharmaceuticals, proteins, gene vectors, and cells - by enabling their site-specific delivery. The application of magnetic...

  • Contents Page.  // Cardiovascular Research;Sep2014, Vol. 103 Issue 4, pNP 

    No abstract available.

  • European Physicians Are Receptive to Drug-Eluting Balloons for Treatment of Coronary Artery Disease.  // Biomedical Market Newsletter;12/21/2011, Vol. 21, p1 

    The article reports on a research led by the Millennium Research Group (MRG) Inc. according to which the majority of European interventional cardiologists are using drug-eluting balloons (DEBs). The research found that almost 80 percent of European cardiology specialists have adopted DEBs while...

  • Ideal Bioabsorbable Stent Scaffold is an Achievable Dream. Lederman, Lynne // MD Conference Express;Aug2013, Vol. 13 Issue 7, p31 

    The development of metalic stents improved outcomes after angioplasty by reducing acute vessel occlusion. However, permanent metal-based stents have the potential for negative sequelae after several months in place that couls be overcome if the stents were absorbable. This article reviews the...

  • Human recombinant activated protein C-coated stent for the prevention of restenosis in porcine coronary arteries. Lukovic, Dominika; Nyolczas, Noemi; Hemetsberger, Rayyan; Pavo, Imre; Pósa, Aniko; Behnisch, Boris; Horak, Gerhard; Zlabinger, Katrin; Gyöngyösi, Mariann // Journal of Materials Science: Materials in Medicine;Oct2015, Vol. 26 Issue 10, p1 

    Activated protein C (APC), an endogenous protein, inhibits inflammation and thrombosis and interrupts the coagulation cascade. Here, we investigated the effect of human recombinant APC on the development of neointimal hyperplasia in porcine coronary arteries. Yukon Choice bare metal stents were...


Read the Article


Sign out of this library

Other Topics